Catheter Precision Income Statement (2017-2025) | VTAK

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
0.00M1.00M0.01M0.01M0.01M0.01M0.09M0.10M0.13M0.13M0.08M0.09M0.10M0.15M0.14M0.21M0.23M0.24M
Cost of Revenue (Quarter)
0.45M1.49M0.25M0.35M0.10M0.07M-0.04M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.02M0.02M
Gross Profit (Quarter)
-0.44M-0.48M-0.24M-0.34M-0.09M-0.06M0.07M0.09M0.13M0.12M0.08M0.08M0.09M0.14M0.13M0.20M0.21M0.22M
Operating items
Research & Development (Quarter)
2.75M3.02M2.94M3.73M3.12M2.40M0.73M0.15M0.24M0.13M0.11M-0.01M0.04M0.08M0.06M0.09M0.10M0.15M0.28M0.33M
Selling, General & Administrative (Quarter)
3.68M3.74M4.21M4.19M2.30M2.48M3.51M7.96M10.23M1.42M2.75M2.73M2.66M2.71M2.88M3.10M3.48M2.88M2.95M2.76M
Other Operating Expenses (Quarter)
3.53M0.54M0.10M0.08M4.73M0.80M-76.36M-0.06M-1.50M-1.26M0.12M1.85M7.00M
Operating Expenses (Quarter)
6.43M6.76M7.15M7.92M5.42M8.40M4.78M8.21M66.56M6.40M2.86M2.72M2.69M2.79M2.94M3.19M3.71M4.88M3.23M10.08M
Operating Income (Quarter)
-6.87M-7.24M-7.39M-8.26M-5.50M-8.46M-4.78M-8.21M-66.48M-6.31M-2.73M-2.60M-2.62M-2.72M-2.86M-3.05M-3.58M-4.69M-3.02M-9.86M
EBIT (Quarter)
-6.87M-7.24M-7.39M-8.26M-5.50M-8.46M-4.78M-8.21M-66.48M-6.31M-2.73M-2.60M-2.62M-2.72M-2.86M-3.05M-3.58M-4.69M-3.02M-9.86M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.00M0.02M-0.04M0.07M0.12M0.09M0.05M0.03M0.01M0.01M0.03M0.02M0.00M0.01M0.00M
Other Non Operating Income (Quarter)
-0.01M2.02M0.02M-0.01M-0.01M0.01M0.02M0.06M0.01M-0.00M-0.02M-0.00M-0.00M-0.00M0.01M-0.00M-0.01M0.00M
Non Operating Income (Quarter)
-0.01M1.99M0.02M-0.02M-0.01M0.01M0.02M0.06M0.01M-0.00M7.54M-0.00M-1.50M-1.26M-2.25M-0.00M-0.01M2.16M
Net income details
EBT (Quarter)
-6.88M-5.25M-7.38M-8.28M-5.50M-8.45M-4.76M-8.16M-66.40M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-2.49M-4.77M-6.41M-2.27M-6.06M
Tax Provisions (Quarter)
0.00M1.60M
Profit After Tax (Quarter)
-7.24M-5.25M-7.38M-6.10M-5.50M-8.45M-4.76M-8.16M-66.40M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-5.63M-4.04M-5.46M-2.25M-5.34M
Income from Non-Controlling Interests (Quarter)
-0.35M-0.09M-0.07M
Income from Continuing Operations (Quarter)
-6.88M-5.25M-7.38M-8.28M-5.50M-8.45M-4.76M-8.16M-66.40M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-2.49M-4.77M-6.41M-2.27M-7.66M
Consolidated Net Income (Quarter)
-0.36M-5.25M3.08M-5.50M-8.45M-4.76M-8.16M-66.40M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-2.49M-4.77M-6.41M-2.27M-7.66M
Income towards Parent Company (Quarter)
-0.36M-5.25M3.08M-5.50M-8.45M-4.76M-8.16M-66.40M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-2.49M-4.77M-6.41M-2.27M-7.66M
Net Income towards Common Stockholders (Quarter)
-0.36M-5.25M3.08M-5.50M-8.45M-4.76M-8.16M-67.20M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-10.79M-4.77M-6.41M-2.27M-7.66M
Additional items
EPS (Basic) (Quarter)
-2.48-1.28-33.58-37.40-0.27-0.02-4.362.02-24.65-3.89-2.83-0.61-3.60-5.57-38.1749.36-0.36-0.38-1.70-2.88
EPS (Weighted Average and Diluted) (Quarter)
-57.64-37.40-4.362.02
Shares Outstanding (Weighted Average) (Quarter)
0.00M3.51M128.000.10M400.75M525.92M1,092.24M1.03M2.73M0.41M0.68M1.10M0.74M0.75M0.06M0.17M18.12M20.50M1.08M1.08M
Shares Outstanding (Diluted Average) (Quarter)
128.000.10M0.00M1.03M
EBITDA (Quarter)
-6.87M-7.24M-7.39M-8.26M-5.50M-8.46M-4.78M-8.21M-66.48M-6.31M-2.73M-2.60M-2.62M-2.72M-2.86M-3.05M-3.58M-4.69M-3.02M-9.86M
Interest Expenses (Quarter)
0.05M0.03M-0.02M0.00M0.01M0.03M-0.03M0.05M0.07M0.08M0.05M
Tax Rate (Quarter)
-0.04%-26.33%